Rapid Test Detects ARDS Subtypes
An immunoassay measured key inflammatory biomarkers and classified patients into two ARDS subtypes—hyperinflammatory and hypoinflammatory—within approximately one hour.
Category: ARDS
ARDS
Latest
Rapid Test Detects ARDS Subtypes
An immunoassay measured key inflammatory biomarkers and classified patients into two ARDS subtypes—hyperinflammatory and hypoinflammatory—within approximately one hour.
Read More
High-flow Nasal Cannula Reduced Intubation, Not Mortality
Compared to standard O2 therapy, high-flow nasal cannula did not lower mortality in in acute hypoxemic respiratory failure but may reduce the need for intubation, according to new data from the SOHO trial.
Read More
Neonatal Respiratory Depression Tied to Maternal Oxycodone Use During Breastfeeding
A case report suggests high doses of oxycodone in breastfeeding mothers can lead to apnea and bradycardia in newborns due to immature metabolic pathways.
Read More
Potential Gene-based Treatment for Sepsis, Lung Injury
Findings suggest that the endothelial gene ALOX15 gene protects against sepsis-induced lung injury.
Read More
Developments in ARF and ARDS Treatment
Acute respiratory failure (ARF) and acute respiratory distress syndrome (ARDS) are critical conditions associated with high mortality. Current management strategies are evolving toward personalized care.
Read More
CDS Sped Ventilator Weaning for Children with ARDS
Ventilators managed by a computerized decision support (CDS) tool shortened the time children with respiratory failure spent on mechanical ventilation.
Read More
Study Uncovers Driver of Endothelial Dysfunction in Sepsis-Induced ARDS
New insights reveal a key factor contributing to vascular injury and lung dysfunction in sepsis-induced ARDS.
Read More
COVID-Induced ARDS Linked to Heart Damage
Researchers have a new understanding of the link between this serious lung injury and the kind of inflammation that can lead to cardiovascular complications.
Read More
Immune Response Byproduct Key Factor in ARDS Severity
Researchers may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome, particularly in the aftermath of respiratory illnesses such as COVID-19 or pneumonia.
Read More
High-dose Inhaled Nitric Oxide Decreased ARDS-related Mortality Risk in Black Patients with COVID-19
High-dose inhaled nitric oxide (iNO) therapy may improve oxygenation and reduce the risk of ARDS-related mortality among critically ill Black patients with COVID-19, according to a first-of-its-kind study published in the American Journal of Respiratory and Critical Care Medicine.
Read More
Hispanic Patients with Respiratory Failure Five Times More Likely to Be Oversedated
Researchers say different levels of sedation may explain disparities in deaths from respiratory failure.
Read More
New Cell Therapy Reduces Mortality for COVID-19-related ARDS
An initial trial suggests invariant natural killer cell therapy improves survival.
Read More
Scientists ID Respiratory Microbiome Signatures Tied to ARDS, HAP
Researchers say they have identified “robust” respiratory microbiome signatures associated with ARDS and HAP.
Read More
NIH Grant Awarded to Study Pharmaceutical Therapies for ARDS
UTHealth Houston researchers were awarded a four-year, $3.4 million NIH grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome.
Read More
Pulse Oximetry, Ultrasound, and HFNO as New ARDS Standards
Experts have proposed a new definition for acute respiratory distress syndrome, reflecting recent research and advancements in diagnosis and treatment.
Read More
Obesity May Not Hinder ECMO Treatment in ARDS Patients
A National Institutes of Health-supported study suggests that adults with obesity may benefit from the use of extracorporeal membrane oxygenation when in intensive care for respiratory failure.
Read More
Therapy Derived from Skin Cells May Be Able to Treat Injured Lungs
The hope is that a drop of solution containing these nanocarriers, delivered to the lungs via the nose, could treat acute respiratory distress syndrome.
Read More
AACN Practice Alert: Manual Prone Positioning Guidance for ARDS Patients
A new AACN Practice Alert summarizes expected clinical practice to reduce the risk of complications related to manual prone positioning.
Read More
UIC Scientists Receive $13 Million to Study Lung Inflammation Mechanisms
The researchers hope the projects will lead to new avenues for treatments to help patients with conditions like COPD, pulmonary fibrosis, and acute respiratory distress syndrome.
Read More
Novel Peptide Suppresses ARDS-related Lung Inflammation
The C6 peptide inhibited the process that triggers uncontrolled inflammation and fluid buildup that can lead to ARDS.
Read More
Electrical Stimulation Treats Opioid-induced Respiratory Depression
A novel treatment for opioid-induced respiratory depression that administers electrical pulses to the back of the neck helped anesthetized patients undergoing neurosurgery regain respiratory control following high dosage opioid use.
Read More
Study Evaluates Inhaled Nitric Oxide for COVID-19
Researchers assessed outcomes of INOmax inhaled nitric oxide for COVID-19 patients hospitalized with mild-to-moderate ARDS.
Read More
7% of US Lung Transplants Went to Severe COVID Patients
7% of the nation’s more than 3,000 lung transplants between Aug. 1, 2020, and Sept. 30, 2021 were performed to treat severe, irreversible lung damage caused by COVID-19.
Read More
Noninvasive Ventilation Mitigates Harm to Preterm Infants Suffering Respiratory Distress Syndrome
Noninvasive ventilation methods for respiratory distress syndrome have gained attention in recent years due to rising incidence of bronchopulmonary dysplasia in intubated infants.
Read More